DRKS00006297招募中不适用
Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum
Klinik für Radio-OnkologieUniversitätsSpital Zürich0 个研究点目标入组 300 人开始时间: 2014年7月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •NSCLC treated with stereotactic body radiotherapy or nomally fractionated radiotherapy. In addition, patients with cancers of different origin and treated with SBRT may also be included for biomarker analysis.
排除标准
- •Postoperative radiotherapy. Pregnant or lactating women.
研究者
相似试验
尚未招募
不适用
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000041659Saitama Medical University International Medical Center20
已完成
不适用
Dynamics of tumour hypoxia and metabolism during Chemoradiotherapy for stage III Non Small Cell Lung Cancer, using 18F-FAZA-PET/CT and 18F-FDG-PET/CT. A Pilot Studynon-small-cell-lung-cancer10038666NL-OMON39397niversitair Medisch Centrum Groningen10
已完成
不适用
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CThoofd hals kankerHypoxia in locally advanced Head and Neck cancer10027656NL-OMON36574niversitair Medisch Centrum Groningen20
终止
2 期
Tumor Hypoxia With HX4 PET in Several DiseasesEsophageal NeoplasmsNeoplasm Metastases, BrainRectal NeoplasmsBrain Neoplasm, PrimaryProstatic NeoplasmsNCT02584400Maastricht Radiation Oncology1
已完成
不适用
Tumor hypoxia measured with F-MISO-PET in the course of irradiation of head and neck cancer: adoption of the method into clinical routine and evaluation of the dataC10C13Malignant neoplasm of oropharynxMalignant neoplasm of hypopharynxDRKS00006007niversitätsklinikum DresdenKlinik für Strahlentherapie und Radioonkologie59